Glaukos CorporationGKOSNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank15
3Y CAGR-22.2%
5Y CAGR-16.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-22.2%/yr
vs -5.5%/yr prior
5Y CAGR
-16.1%/yr
Recent deceleration
Acceleration
-16.6pp
Decelerating
Percentile
P15
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 10.40% |
| 2024 | -1.69% |
| 2023 | 12.57% |
| 2022 | 22.05% |
| 2021 | 18.28% |
| 2020 | 25.01% |
| 2019 | 37.51% |
| 2018 | 27.69% |
| 2017 | 33.13% |
| 2016 | 16.67% |